Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105705314 | 10570531 | 4 | F | 2006 | 20160802 | 20141107 | 20160809 | EXP | US-009507513-1411USA000525 | MERCK | 0.00 | F | Y | 0.00000 | 20160809 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105705314 | 10570531 | 1 | PS | FOSAMAX | ALENDRONATE SODIUM | 1 | Oral | 70 MG, QW | 20560 | 70 | MG | TABLET | /wk | ||||||
| 105705314 | 10570531 | 2 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | 50 K, UNKNOWN | U | 0 | |||||||||
| 105705314 | 10570531 | 3 | C | OMEGA-3 MARINE TRIGLYCERIDES | FISH OIL | 1 | Unknown | 1250 MG, UNKNOWN | U | 0 | |||||||||
| 105705314 | 10570531 | 4 | C | OCUVITE LUTEIN (ascorbic acid (+) beta carotene (+) copper (unspecifie | 2 | Unknown | UNK, UNKNOWN | U | 0 | ||||||||||
| 105705314 | 10570531 | 5 | C | CITRACAL | CALCIUM CITRATE | 1 | Unknown | 500 MG, UNKNOWN | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 105705314 | 10570531 | 1 | Osteoporosis |
| 105705314 | 10570531 | 2 | Product used for unknown indication |
| 105705314 | 10570531 | 3 | Product used for unknown indication |
| 105705314 | 10570531 | 4 | Product used for unknown indication |
| 105705314 | 10570531 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 105705314 | 10570531 | OT |
| 105705314 | 10570531 | HO |
| 105705314 | 10570531 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 105705314 | 10570531 | Arthralgia | |
| 105705314 | 10570531 | Arthropathy | |
| 105705314 | 10570531 | Back pain | |
| 105705314 | 10570531 | Fall | |
| 105705314 | 10570531 | Femur fracture | |
| 105705314 | 10570531 | Impaired healing | |
| 105705314 | 10570531 | Joint dislocation | |
| 105705314 | 10570531 | Osteoarthritis | |
| 105705314 | 10570531 | Pain | |
| 105705314 | 10570531 | Parkinson's disease | |
| 105705314 | 10570531 | Restless legs syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 105705314 | 10570531 | 1 | 2001 | 201110 | 0 | |
| 105705314 | 10570531 | 2 | 2000 | 0 | ||
| 105705314 | 10570531 | 3 | 2000 | 0 | ||
| 105705314 | 10570531 | 4 | 2000 | 0 | ||
| 105705314 | 10570531 | 5 | 2000 | 0 |